Microneedle Arrays: Advancements, Applications and Future Prospects in Pharmaceutical Delivery

 

Prakash Nathaniel Kumar Sarella*, Surekha Valluri, Srujala Vegi, Veera Kumari Vendi,

Anil Kumar Vipparthi

Department of Pharmaceutics, Aditya College of Pharmacy,

ADB Road, Surampalem, Kakinada 533437, Andhra Pradesh, India.

*Corresponding Author E-mail: sarellaprakash@acop.edu.in

 

ABSTRACT:

Microneedle arrays have emerged as a cutting-edge technology revolutionizing the field of pharmaceutical delivery. These micron-sized needles offer a minimally invasive and painless approach to administer drugs, vaccines, and various therapeutic agents through the skin, bypassing traditional routes of administration. This review article comprehensively explores the advancements, applications, and future prospects of microneedle arrays in pharmaceutical delivery. This review delves into the different types of microneedle arrays, including solid, hollow, dissolving, and coated microneedles, highlighting their unique properties and fabrication techniques. The discussion encompasses recent breakthroughs in microneedle design, such as biodegradable materials, smart responsive systems, and personalized arrays tailored to specific patient needs. Furthermore, this review addresses the challenges and safety considerations associated with microneedle usage, such as skin irritation and regulatory aspects. It analyzes ongoing research efforts aimed at optimizing design, functionality, and scalability for large-scale manufacturing. The future prospects of microneedle arrays in pharmaceutical delivery qwew also discussed. Anticipated advancements in the field, including personalized medicine, combination therapy, and disease monitoring through biosensing, offer promising avenues for transformative healthcare solutions. In conclusion, microneedle arrays represent a paradigm shift in pharmaceutical delivery, offering numerous advantages over traditional methods. As research and development continue, these micro-sized devices hold the potential to revolutionize the landscape of drug administration, leading to safer, more effective, and patient-centric healthcare practices.

 

KEYWORDS: Microneedle arrays, Pharmaceutical delivery, Drug delivery technology, Minimally invasive administration, Transdermal drug delivery.

 

 


 

INTRODUCTION:

Microneedle arrays have emerged as a groundbreaking technology with immense potential to revolutionize the field of pharmaceutical delivery. These miniature needle-based systems offer a minimally invasive and painless approach to administer drugs, vaccines, and various therapeutic agents through the skin, presenting a compelling alternative to conventional routes of drug administration1,2. In recent years, extensive research and development efforts have fueled significant advancements in microneedle design and fabrication, unlocking new possibilities in drug delivery and patient care.

 

This review article aims to explore the various facets of microneedle arrays in pharmaceutical delivery, shedding light on their applications, benefits, challenges, and future prospects. The following sections delve into the different types of microneedle arrays, including solid, hollow, dissolving, and coated microneedles, elucidating their unique features and potential applications. Moreover, the article will discuss the latest breakthroughs in microneedle design, such as the incorporation of biodegradable materials and smart responsive systems, enabling personalized and targeted drug delivery. The extensive range of pharmaceutical applications of microneedle arrays, from vaccine administration and biologics delivery to managing chronic diseases and providing pain relief, will also be comprehensively explored.

 

Types of microneedle arrays:

Microneedle arrays encompass a diverse range of designs and structures, each tailored to specific pharmaceutical delivery needs. These micro-sized needles can be categorized into several distinct types, each offering unique advantages in drug delivery. Each type of microneedle array has its own set of advantages and limitations, and the choice of microneedle design depends on the specific drug being delivered, the desired release profile, and the targeted application. The versatility of microneedle arrays holds immense promise in transforming pharmaceutical delivery, enabling more effective, patient-friendly, and personalized therapeutic interventions. Continued research and innovation in this field will undoubtedly lead to further advancements and expanded applications for microneedle arrays in the realm of healthcare3. The following are the key types of microneedle arrays:

 

a.     Solid microneedles:

Solid microneedles are the simplest and most common type of microneedles. They consist of solid, needle-like structures made from various materials such as silicon, metals, or biodegradable polymers. Solid microneedles are typically used for the delivery of small-molecule drugs and vaccines. Their sharp tips facilitate easy penetration into the skin, creating microchannels through which the drug is delivered directly to the underlying tissue2. Solid microneedles are particularly suitable for delivering therapeutics that can be formulated into solid-state formulations.

 

b.    Hollow microneedles:

Hollow microneedles, as the name suggests, have a hollow center. These microneedles enable the delivery of a wider range of drugs, including biologics, proteins, and even gene-based therapeutics that require precise and controlled delivery. The hollow channel allows the drug to flow through the microneedle, reaching deeper layers of the skin or into the bloodstream. Hollow microneedles are especially beneficial for sensitive drugs that may degrade when exposed to the external environment4.

 

c.     Dissolving microneedles:

Dissolving microneedles, also known as biodegradable microneedles, are designed to dissolve within the skin after drug delivery. These microneedles are fabricated using materials that can dissolve upon contact with the skin's interstitial fluid, releasing the loaded drug. Dissolving microneedles offer several advantages, including eliminating the need for needle disposal and reducing the risk of cross-contamination. They are particularly suitable for delivering vaccines and labile biologics2.

 

d.    Coated microneedles:

Coated microneedles have a solid core with a drug-coated surface. The drug coating is designed to dissolve or release upon skin insertion, ensuring controlled drug delivery. Coated microneedles provide a versatile platform for delivering a wide range of drugs with different release kinetics. They can be tailored to deliver drugs at specific rates, making them suitable for sustained release formulations or sequential drug delivery5.

 

A comparative analysis of microneedle arrays is shown in Table 1.


 

Table 1: Comparison of Microneedle Array Types

Microneedle Array Type

Advantages

Applications

Limitations

Solid Microneedles

·    Easy fabrication

·    Painless insertion

·    Suitable for simple drug formulations

·    Small-molecule drugs, vaccines

·    Pain relief medications, Dermatological therapies

·    Limited drug payload capacity,

·    Cannot deliver large molecules

Hollow Microneedles

·    Delivery of larger molecules

·    Precise drug delivery

·    Reduced drug degradation

·    Biologics and protein therapeutics

·    Targeted therapy

·    Requires precise drug loading

·    More complex fabrication process

Dissolving Microneedles

·    No needle disposal required

·    Controlled drug release

·    Suitable for self-administration

·    Vaccine delivery

·    Labile biologics

·    Point-of-care applications

·    Limited to drug stability in matrices

·    May require specialized formulations

 


Advancements in Microneedle Design:

Advancements in microneedle array design have been instrumental in enhancing the functionality, efficiency, and patient-friendliness of these innovative drug delivery systems. Researchers and engineers have continuously pushed the boundaries of design principles to overcome challenges and improve the performance of microneedles6. The following are some notable advancements in microneedle array design:

 

a.     Biodegradable Materials:

One significant advancement in microneedle design is the use of biodegradable materials. Traditional microneedles were often made from non-biodegradable materials, requiring additional steps for disposal after use. However, biodegradable microneedles are crafted from materials that can safely degrade within the body over time. These materials may include biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA) or sugar-based materials like maltose or sucrose. Biodegradable microneedles eliminate the need for post-use needle disposal, reducing environmental waste and simplifying the overall drug delivery process7.

 

b.    Smart Responsive Systems:

Advancements in smart responsive systems have introduced a new level of control and precision in drug delivery. Smart microneedle arrays can be designed to respond to specific stimuli, such as changes in pH, temperature, or enzyme activity. When exposed to these stimuli at the target site, the microneedles can trigger drug release or change their shape to adapt to the surrounding environment8. This feature allows for on-demand drug delivery, tailored to the patient's needs and specific medical conditions.

 

c.     Personalized Microneedle Arrays:

The concept of personalized medicine has extended to microneedle array design. Researchers are exploring ways to create microneedle arrays that can be customized for individual patients, based on their unique physiological characteristics and therapeutic requirements. Personalized microneedles may involve adjusting the length, shape, and spacing of the microneedles to suit different skin types and drug dosages, ensuring optimized drug delivery with minimal discomfort8.

 

d.    Composite Microneedles:

Composite microneedles combine multiple functionalities within a single array. For instance, a composite microneedle may contain both drug-coated and dissolving microneedles, offering a versatile platform for delivering different types of drugs simultaneously or in a controlled sequence9. This approach maximizes the utility of microneedle arrays and expands their potential applications in complex therapeutic regimens.

 

e.     Microneedle Patch Systems:

Advancements in microneedle patch systems have made drug administration even more user-friendly and accessible through the usage of microneedle patch systems. Microneedle patches are adhesive patches with integrated microneedle arrays that can be simply applied to the skin by the patient. The microneedles painlessly penetrate the skin, delivering the drug payload, and the patch can be easily removed and discarded after use10. These patches are ideal for self-administration of vaccines and certain medications, reducing the reliance on healthcare professionals for drug delivery.

 

Pharmaceutical applications: Microneedle arrays have garnered significant attention in the pharmaceutical industry due to their wide range of applications in drug delivery. Their minimally invasive nature and ability to overcome various biological barriers make them an attractive platform for delivering diverse types of pharmaceuticals. The following are some of the key pharmaceutical applications of microneedle arrays:

 

a.     Vaccine Delivery:

One of the most promising applications of microneedle arrays is in vaccine delivery. Vaccines are crucial for preventing infectious diseases, but traditional needle-based injections can be intimidating and lead to vaccine hesitancy. Microneedle arrays offer a painless and patient-friendly alternative for vaccine administration. These arrays can effectively deliver vaccines through the skin's epidermal layer, targeting antigen-presenting cells and eliciting robust immune responses. Microneedle-based vaccines have demonstrated comparable or even enhanced immunogenicity compared to conventional injections, making them a potential game-changer in vaccination programs worldwide11.

 

b.    Biologics and Protein Therapeutics:

The delivery of biologics and protein-based therapeutics presents unique challenges due to their susceptibility to degradation and instability during traditional administration routes. Microneedle arrays, especially hollow or dissolving microneedles, provide a solution by delivering these delicate drugs directly to the systemic circulation or the lymphatic system12. The controlled and targeted delivery offered by microneedle arrays ensures improved bioavailability and therapeutic efficacy, potentially transforming the treatment of various chronic diseases like diabetes, arthritis, and cancer.

 

c.     Management of Chronic Diseases:

Microneedle arrays have demonstrated great potential in managing chronic diseases by providing a convenient and controlled drug delivery mechanism. For conditions requiring regular medication, such as diabetes, hypertension, or hormone replacement therapy, microneedle patches offer a patient-friendly option. These patches can deliver drugs over extended periods, reducing the need for frequent injections or oral dosing, thereby improving patient compliance and treatment outcomes13.

 

d.    Pain Relief Medications:

Localized pain relief medications, such as lidocaine or ibuprofen, can be efficiently delivered using microneedle arrays. Solid microneedles, when applied to the affected area, can rapidly deliver pain-relieving drugs through the skin, offering quick and targeted relief. This approach is particularly valuable in cases where oral medications may have side effects or take longer to produce the desired effect14.

 

e.     Cosmeceuticals and Dermatological Therapies:

Microneedle arrays have found applications in the delivery of cosmeceuticals and dermatological therapies. Cosmetic formulations, including anti-aging compounds and skin rejuvenation treatments, can be delivered through microneedles to promote skin health and appearance15. Additionally, microneedle arrays are used for dermatological therapies like topical steroids for skin conditions such as psoriasis and vitiligo.

 

f.      Pediatric and Geriatric Care:

Microneedle arrays offer distinct advantages in pediatric and geriatric care settings. Children and elderly patients often experience difficulties with conventional injections due to fear, discomfort, or issues with veins. Microneedle arrays present a less intimidating and painless alternative, making drug administration more manageable for these vulnerable patient populations16.

 

The advantages of using microneedle arrays over other dosage forms are listed in Table 2.

 

Safety Regulations of using Microneedle arrays in Drug Delivery:

Ensuring the safety and regulatory compliance of microneedle arrays is of paramount importance to facilitate their widespread adoption in pharmaceutical delivery. While microneedles offer numerous advantages, certain safety considerations must be addressed to ensure patient well-being. Additionally, regulatory approvals from health authorities are essential to validate their efficacy and safety17. The following are key aspects related to the safety and regulations surrounding microneedle arrays:

 

a.     Skin Irritation and Allergic Reactions:

One primary safety concern with microneedle arrays is the potential for skin irritation and allergic reactions. The skin's response to microneedle insertion can vary among individuals, and some may experience mild redness or irritation at the application site. It is crucial to assess and mitigate these reactions through rigorous testing and optimization of materials and designs. Biocompatibility studies and skin irritation tests are essential to ensure that the materials used in microneedle arrays are well-tolerated by the skin and do not cause adverse reactions18.

 

b.    Infection Risk:

The risk of infection associated with microneedle insertion is generally low, as the microneedles create micro-sized channels that typically heal quickly without significant open wounds. However, proper sterilization of the microneedle arrays and maintaining aseptic techniques during manufacturing and application are critical to minimizing infection risks19.

 

c.     Regulatory Approvals:

Regulatory approvals are a pivotal step in establishing the safety and efficacy of microneedle arrays for pharmaceutical delivery. Health authorities, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), evaluate the safety and performance of these devices before granting marketing authorization. Manufacturers must conduct comprehensive preclinical and clinical studies to demonstrate the safety, efficacy, and quality of the microneedle arrays before seeking regulatory approval19.


 

Table 2: Advantages of microneedle arrays in drug delivery

Advantages

Importance in Pharmaceutical Delivery

Painless and Minimally Invasive

Improves patient compliance and reduces fear of injections.

Enables painless delivery of vaccines and medications.

Enhanced Transdermal Drug Delivery

Overcomes the skin's barrier for improved drug absorption.

Offers a non-invasive alternative to injections for systemic drugs.

Tailored Drug Release

Allows precise control over drug release kinetics and dosing.

Enables personalized medicine and targeted therapy.

Versatile Drug Formulations

Accommodates a wide range of drug types, including biologics.

Facilitates the delivery of labile drugs without degradation.

Needle-Free and User-Friendly

Reduces needle phobia and risk of needlestick injuries.

Enables self-administration of drugs for certain conditions.

Enhanced Vaccine Delivery

Enhances immune responses for more effective vaccination.

Simplifies mass vaccination campaigns in pandemic situations.


d.    Biocompatibility and Toxicity Testing:

Before clinical trials and regulatory submissions, extensive biocompatibility and toxicity testing are necessary to assess the interactions between the microneedle materials and the human body20. These tests evaluate the potential for adverse effects and ensure that the materials used are safe for intended use.

 

e.      Human Clinical Trials:

Conducting well-designed human clinical trials is crucial to gather data on the safety and efficacy of microneedle arrays in real-world settings. Clinical trials should adhere to ethical principles, and their results play a significant role in obtaining regulatory approvals and establishing the clinical utility of microneedle-based drug delivery systems21.

 

f.      Post-Market Surveillance:

After receiving regulatory approvals and entering the market, post-market surveillance is essential to monitor the safety and performance of microneedle arrays on a larger scale. Tracking adverse events and gathering real-world data further strengthens the understanding of their safety profile and contributes to continuous improvement.

 

Meeting safety standards and obtaining regulatory approvals are critical milestones for microneedle arrays' successful integration into pharmaceutical delivery practices22. By adhering to rigorous safety assessments and regulatory processes, manufacturers can build confidence in the use of microneedle arrays, leading to enhanced patient care and improved healthcare outcomes.

 

Future prospects:

The future of microneedle arrays in pharmaceutical delivery holds tremendous promise, as ongoing research and development efforts continue to push the boundaries of this groundbreaking technology. Several exciting prospects lie ahead, with the potential to transform healthcare practices and patient outcomes23. The following are some of the key future prospects for microneedle arrays:

 

a.     Personalized Medicine and Targeted Therapies:

Advancements in microneedle array design, such as personalized microneedles, will enable the delivery of tailored treatments for individual patients. By considering patient-specific factors such as skin type, drug dosage requirements, and treatment schedules, microneedles can optimize drug delivery and efficacy. This personalized medicine approach has the potential to improve treatment outcomes and minimize adverse effects, making therapies more effective and patient-friendly24. An illustration of personalized medicine using microneedles is shown in Figure 1.

 

Figure 1: Smart Microneedle Array for Personalized Drug Delivery

 

b.    Combination Therapy with Microneedles:

Microneedle arrays can facilitate the concurrent delivery of multiple drugs, enabling combination therapies for complex medical conditions. For example, microneedles could simultaneously deliver drugs with complementary mechanisms of action to enhance treatment efficacy and address various aspects of a disease. Combination therapy using microneedles may offer a new frontier in cancer treatment, infectious diseases, and chronic conditions, fostering synergistic therapeutic effects25.

 

c.     Disease Monitoring and Biosensing:

Advancements in microneedle technology may lead to the incorporation of biosensors into the microneedle arrays. These biosensors could monitor biomarkers in the interstitial fluid, providing real-time data on a patient's health status. Such a non-invasive and continuous monitoring approach could revolutionize disease management for conditions like diabetes, providing early detection of complications and enabling timely intervention26.

 

d.    Painless Vaccination Strategies:

Painless and needle-free vaccination strategies have the potential to improve vaccine coverage rates and reduce vaccine hesitancy. Microneedle arrays offer an attractive solution, as they can deliver vaccines painlessly through the skin, bypassing the need for traditional needle injections17. This approach could play a crucial role in global vaccination efforts, especially in hard-to-reach populations and during pandemics.

 

 

e.     Wearable and Implantable Devices:

Advancements in material science and microneedle fabrication techniques may pave the way for wearable and implantable microneedle devices. Wearable patches with integrated microneedles could provide continuous drug delivery, eliminating the need for frequent injections and improving patient compliance. Implantable microneedle arrays could also offer sustained drug release for chronic conditions, reducing the burden of frequent dosing19.

 

f.      Point-of-Care Applications

Microneedle arrays have the potential to revolutionize point-of-care applications, enabling healthcare providers to deliver medications and therapies quickly and effectively. In emergency situations or remote settings, microneedles could offer a rapid and painless means of drug administration, saving valuable time and enhancing patient outcomes27.

 

The ongoing advancements and innovative research in microneedle array technology herald an exciting era in pharmaceutical delivery. As these prospects become a reality, microneedles are likely to play a transformative role in healthcare, offering more precise, patient-centric, and accessible treatment options. However, as the field progresses, it remains essential to address safety, scalability, and regulatory considerations to ensure that these novel drug delivery systems are effectively integrated into clinical practice, benefiting patients worldwide.

 

Challenges and research:

Despite the tremendous potential of microneedle arrays in pharmaceutical delivery, several challenges need to be addressed to optimize their performance and widespread adoption. Researchers and engineers are actively working to overcome these challenges through ongoing research and development efforts21. The following are some of the key challenges and areas of research in the field of microneedle arrays:

 

a.     Scalability and Mass Production:

One of the primary challenges is the scalability of microneedle array production. While lab-scale fabrication methods exist, scaling up the production process to meet commercial demand is complex. Techniques that can ensure consistent quality, reproducibility, and cost-effectiveness are under exploration to enable large-scale manufacturing of microneedle arrays23.

 

b.    Long-Term Stability:

The stability of microneedle arrays during storage and transportation is crucial for their practical implementation. Maintaining the integrity of the microneedles and the drug formulation over extended periods without loss of efficacy is a key research focus28. Studies are ongoing to optimize materials and packaging to enhance the long-term stability of microneedle arrays.

 

c.     Enhanced Drug Loading Capacity:

Maximizing the drug loading capacity of microneedle arrays is essential for delivering therapeutics with higher doses or larger molecular sizes. Researchers are investigating novel drug formulations and delivery methods to achieve higher drug payloads while maintaining the mechanical properties and performance of the microneedles29.

 

d.    Biocompatibility and Safety:

Ensuring the biocompatibility and safety of microneedle materials is an ongoing research area. While many microneedle materials are biocompatible, comprehensive and standardized biocompatibility studies are essential to establish their safety profile and address any potential concerns29.

 

e.     Microfabrication Techniques:

Advancements in microfabrication techniques play a crucial role in enhancing the precision and versatility of microneedle arrays. Researchers are exploring innovative methods, such as 3D printing and micromolding, to create complex microneedle geometries and enable the integration of biosensors or other functionalities within the microneedles20.

 

f.      Transdermal Permeation Enhancement:

To expand the range of drugs that can be delivered via microneedles, research is focused on improving transdermal permeation enhancement techniques30. Strategies such as pretreatment of the skin or the use of chemical permeation enhancers are being explored to increase drug delivery across the skin's barrier (shown in Figure 2).

 

Figure 2: Transdermal Permeation Enhancement Techniques

 

g.     Regulatory Pathways:

Navigating regulatory pathways for microneedle arrays can be challenging due to their unique design and drug delivery mechanisms. Establishing guidelines and standards specific to microneedle-based drug delivery systems will help streamline the regulatory approval process and facilitate their integration into clinical practice31.

 

h.    Combination Products and Patch Compatibility:

Combination products that integrate drug delivery with sensing capabilities or feedback mechanisms are an area of active research. Developing compatible patches and devices to work synergistically with microneedles is crucial to ensure efficient drug delivery and monitoring. The future research centered around microneedles is shown in Table 3:

 

Table 3: Future applications of microneedle arrays

Potential Applications

Importance in Advancing Pharmaceutical Delivery

Continuous Glucose Monitoring

Enables real-time monitoring of blood glucose levels.

Improves diabetes management and treatment.

Combination Therapy

Allows simultaneous delivery of multiple drugs.

Enhances treatment efficacy for complex diseases.

On-Demand Drug Delivery

Responds to patient needs for personalized treatments.

Optimizes drug release based on physiological changes.

Biosensing and Feedback Systems

Provides real-time monitoring of biomarkers.

Enables personalized drug dosing and adjustments.

Microneedle Implants

Offers long-term drug delivery for chronic conditions.

Reduces the need for frequent injections.

Microneedle Arrays for Pediatric Patients

Provides painless drug delivery for children.

Improves compliance in young patient populations.

 

CONCLUSION:

In conclusion, microneedle arrays represent a compelling and transformative approach to pharmaceutical delivery, offering numerous advantages over traditional methods. As research and development continue to advance, these tiny yet powerful devices hold the potential to reshape the landscape of drug administration, leading to safer, more effective, and patient-centric healthcare practices.

 

CONFLICT OF INTEREST:

The authors declare no conflicts of interest.

 

ACKNOWLEDGMENTS:

The authors would like to thank Ms. M. Vinny Therissa, Assistant Professor, Aditya College of Pharmacy for her tremendous support during the preparation of this review.

 

REFERENCES:

1.      Kumbhar PS, Jadhav TP, Chopade SS, Gavade TT, Sorate RC, Shinde TU, et al. Microneedles: An advanced approach for transdermal delivery of biologics. Asian Journal of Pharmaceutical Research. 2021; 11(1): 46-54. doi: 10.5958/2231-5691.2021.00010.1

2.      Mehetar M, Darekar S. Microneedles: A Pharmaceutical Review. AJPT Published online May 30, 2023: 146-54. doi: 10.52711/2231-5713.2023.00027

3.      Sharma N, Sharma TK, Pandit V, Ashawat MS. A Smart and Potential approach for Transdermal Drug Delivery using Microneedles: A Review. AJPS. 2021; 11(2): 113-20. doi: 10.52711/2231-5659.2021-11-2-4

4.      More S, Ghadge T, Dhole S. Microneedle: an advanced technique in transdermal drug delivery system. Asian Journal of Research in Pharmaceutical Science. 2013; 3(3): 141-8.

5.      Nagadev C, Rao M, Venkatesh P, Hepcykalarani D, Prema R. A review on transdermal drug delivery systems. Asian Journal of Research in Pharmaceutical Science. 2020; 10(2): 109-14. doi: 10.5958/2231-5659.2020.00021.1

6.      Nagdev SA, Agrawal O, Usman MRM. Transdermal drug delivery system: An overview. Research Journal of Pharmacy and Technology. 2022; 15(3): 1371-7. doi: 10.52711/0974-360X.2022.00229

7.      Pandey S, Srivastava V. An overview on invasomes: Novel vesicular carrier for transdermal drug delivery. Research Journal of Topical and Cosmetic Sciences. 2021; 12(2): 107-12. doi: 10.52711/2321-5844.2021.00015

8.      Roge AB, Sakhare RS, Bakal RL, Channawar MA, Bakde BV, Gawande SR, et al. Ethosomes: Novel approach in transdermal drug delivery system. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(1): 23-7.

9.      Patel N, Patel C, Vachhani S, Prajapati ST, Patel CN. Recent Advances in Transdermal Drug Delivery System. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(2): 113-9.

10.   Alam MI, Alam N, Singh V, Alam MS, Ali MS, Anwer T, et al. Type, preparation and evaluation of transdermal patch: a review. World Journal of Pharmacy and Pharmaceutical Sciences. 2013; 2(4): 2199-233.

11.   Asfour MH. Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques. Drug Delivery and Translational Research. 2021; 11: 1-23. doi: 10.1007/s13346-020-00746-z

12.   Choonara BF, Choonara YE, Kumar P, Bijukumar D, Toit LC, Pillay V. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnology Advances. 2014; 32: 1269-82. doi: 10.1016/j.biotechadv.2014.07.006

13.   Zhao L, Zhang C, Abu-Ershaid JM, Li M, Li Y, Naser Y, et al. Smart responsive microarray patches for transdermal drug delivery and biological monitoring. Advanced Healthcare Materials. 2021; 10(20): 2100996. doi: 10.1002/adhm.202100996

14.   Donnelly RF, Larrañeta E. Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. Drug Discovery Today. 2018; 23(5): 1026-33. doi: 10.1016/j.drudis.2017.10.013

15.   Tekko IA, Vora LK, Volpe-Zanutto F, Moffatt K, Jarrahian C, McCarthy HO, et al. Novel Bilayer Microarray Patch-Assisted Long-Acting Micro-Depot Cabotegravir Intradermal Delivery for HIV Pre-Exposure Prophylaxis. Advanced Functional Materials. 2022; 32(9): 2106999.

16.   Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyin D, et al. 3D-printed microarray patches for transdermal applications. JACS Au. 2022; 2(11): 2426-45. doi: 10.1021/jacsau.2c00432

17.   Giffen PS, Bhuiya R, Brackenborough K, Hobbs MJ, Qian L, Burke MD. Controlled delivery of dutasteride using dissolvable microarrays: Initial formulation and in vivo evaluation. Journal of Pharmaceutical Sciences. 2020; 109(3): 1303-11. doi: 10.1016/j.xphs.2019.11.012

18.   Ramöller IK, McAlister E, Bogan A, Cordeiro AS, Donnelly RF. Novel design approaches in the fabrication of polymeric microarray patches via micromoulding. Micromachines. 2020; 11(6): 554. doi: 10.3390/ mi11060554

19.   Anjani QK, Sabri AHB, Hutton AJ, Cárcamo-Martínez Á, Wardoyo LAH, Mansoor AZ, et al. Microarray patches for managing infections at a global scale. Journal of Controlled Release. 2023; 359: 97-115. doi: 10.1016/j.jconrel.2023.05.038

20.   Chandrasekhar S, Iyer LK, Panchal JP, Topp EM, Cannon JB, Ranade VV. Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications. Expert Opinion on Drug Delivery. 2013; 10(8): 1155-70. doi: 10.1517/17425247.2013.797405

21.   Paredes AJ, Ramöller IK, McKenna PE, Abbate MT, Volpe-Zanutto F, Vora LK, et al. Microarray patches: breaking down the barriers to contraceptive care and HIV prevention for women across the globe. Advanced Drug Delivery Reviews. 2021; 173: 331-48. doi: 10.1016/j.addr.2021.04.002

22.   Ramadon D, Permana AD, Courtenay AJ, McCrudden MT, Tekko IA, McAlister E, et al. Development, evaluation, and pharmacokinetic assessment of polymeric microarray patches for transdermal delivery of vancomycin hydrochloride. Molecular Pharmaceutics. 2020; 17(9): 3353-68. doi: 10.1021/acs.molpharmaceut.0c00431

23.   Mc Crudden MT, Larrañeta E, Clark A, Jarrahian C, Rein-Weston A, Creelman B, et al. Design, formulation, and evaluation of novel dissolving microarray patches containing rilpivirine for intravaginal delivery. Advanced Healthcare Materials. 2019; 8(9): 1801510. doi: 10.1002/ adhm.201801510

24.   McKenna PE, Abbate MT, Vora LK, Sabri AH, Peng K, Volpe-Zanutto F, et al. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine. ACS Applied Materials and Interfaces. Published online 2023. doi: 10.1021/acsami.3c05553

25.   Bora P, Kumar L, Bansal AK. Microneedle technology for advanced drug delivery: Evolving vistas. Curr Res Inf Pharm Sci. 2008; 9(1): 7-10.

26.   Bhatia M, Saini M. Formulation and evaluation of curcumin microsponges for oral and topical drug delivery. Progress in Biomaterials. 2018; 7(3): 239-48.

27.   Volpe-Zanutto F, Vora LK, Tekko IA, McKenna PE, Permana AD, Sabri AH, et al. Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis. Journal of Controlled Release. 2022; 348: 771-85. doi: 10.1016/j.jconrel.2022.06.028

28.   Korkmaz E, Balmert SC, Sumpter TL, Carey CD, Erdos G, Falo Jr LD. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Advanced Drug Delivery Reviews. 2021; 171: 164-86. doi: 10.1016/j.addr.2021.01.022

29.   Hutton AR, Ubah O, Barelle C, Donnelly RF. Enhancing the transdermal delivery of ‘next generation’variable new antigen receptors using microarray patch technology: a proof-of-concept study. Journal of Pharmaceutical Sciences. 2022; 111(12): 3362-76. doi: 10.1016/j.xphs.2022.08.027

30.   Rekhawar PK, Chendewar AV, Bakal RL, Shep S, Giradkar K. Novel Method of Transdermal Drug Delivery: Iontophoresis. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(3): 215-9.

31.   Branch SK. Guidelines from the international conference on harmonisation (ICH). Journal of Pharmaceutical and Biomedical Analysis. 2005; 38(5): 798-805.

 

 

 

 

Received on 31.07.2023         Modified on 05.02.2024

Accepted on 27.06.2024   ©Asian Pharma Press All Right Reserved

Asian J. Pharm. Tech. 2024; 14(3):229-236.

DOI: 10.52711/2231-5713.2024.00038